Intradermal Injection Market Analysis and Forecast by Size, Share, Growth, Trends 203

The Intradermal Injection market size is projected to reach US$ 10.36 billion by 2031 from US$ 4.37 billion in 2023. The market is expected to register a CAGR of 11.50% during 2023–2031. The rising strategic developments by manufacturers are likely to remain key trends in the market.

Intradermal Injection Market Analysis

An intradermal (ID) injection is a superficial injection of a substance into the dermis layer of the skin. Certain substances administered via an intradermal (ID) route can result in faster systemic uptake compared with subcutaneous injections. This can lead to a robust immune response for vaccinations, immunology, and novel cancer treatments, as well as faster drug uptake. Additionally, since the administration is nearer to the skin surface, the body's reaction to substances is more easily visible. The mounting prevalence of respiratory diseases and allergies and the increasing adoption of intradermal therapies in aesthetics boost the demand for Intradermal Injections.

Intradermal Injection Market Overview

As Highlighted by the Aesthetic Plastic Surgery National Databank, in 2020, over 7 million aesthetic procedures were performed in the US, among which the toxins and fillers, were leading with about 3.9 million procedures. Intradermal injections are mainly used to deliver various neurotoxins related to anti-aging treatments. The rising number of aesthetic procedures involving intradermal therapies is increasing the demand for intradermal injections. Additionally, expanding the application of intradermal injections in dermatology for the treatment of skin and hair diseases is likely to offer growth opportunities in the intradermal injection market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Intradermal Injection Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Intradermal Injection Market Drivers and Opportunities

Mounting Number of Respiratory Infections to Favor Market

According to a factsheet released by WHO in November 2023, around 10.6 million individuals contracted tuberculosis (TB) globally in 2022. Many respiratory diseases, including TB, influenza, and COVID-19, can be diagnosed by tuberculin skin test, which involves intradermal injection. The increasing prevalence of these diseases has led to an increase in the development of intradermal injections for treatment and diagnosis. For instance, in 2020, the FDA approved Fluzone, an intradermal vaccine of influenza developed by Sanofi. The injection is rapidly overtaking the influenza vaccine market and replacing the congenital treatments for these diseases. In addition, Pfizer received approval for its intradermal COVID-19 vaccine named Comirnaty for people above 16 years of age. Such developments by the market players are boosting the global Intradermal Injection market.

Expanding Applications in Dermatology Brings Growth Opportunities

Intradermal therapy, also called mesotherapy, involves a series of micro-injections of active ingredients into the superficial layer of the skin. While it has various clinical applications, it can be instrumental in dermatology for treating many patients. Various studies are being conducted to assess the efficacy and benefits of intradermal injections in treating dermatological conditions. For instance, in an article published in the Journal of Plastic & Reconstructive Surgery in April 2024, a study was carried out to investigate the impact of mechanical factors (syringe and needle size, length, and skin booster viscosity) on the force needed for intradermal injection in porcine skin. The study concluded that the administration of skin boosters via intradermal injections with smaller syringe diameters under optimal conditions maximizes rejuvenating outcomes. These ongoing studies are anticipated to help in the development of potential intradermal treatments in dermatology, offering lucrative growth opportunities in the intradermal injection market.

Intradermal Injection Market Report Segmentation Analysis

Key segments that contributed to the derivation of the intradermal injection market analysis are method, application, and end user.

• The is segmented based on the method into normal-sized needles, short needles, and needles without needles. The normal-sized needles segment held the largest market share in 2023.
• The intradermal injection market is segmented based on application into tuberculin skin tests, allergy tests, local aesthetics, and others. The tuberculin skin test segment held the largest share of the market in 2023.
• By end user, the market is segmented into hospitals, diagnostic laboratories, academics, research institutes, and others. The hospitals segment held the largest share of the market in 2023.

Intradermal Injection Market Share Analysis by Geography

The geographic scope of the Intradermal Injection market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.  Asia Pacific is estimated to grow with the highest CAGR in the coming years.

The Intradermal Injection market in North America is analyzed based on the three major countries: the US, Canada, and Mexico. The US is projected to have the largest share of the North American intradermal Injection market in 2023.

TB is one of the major bacterial infections in well-matured countries, including the US. According to the statistics published by the Centres of Disease Control and Prevention (CDC) in 2024, about 13 million individuals are living in the US with latent TB, while in 2022, 8,331 cases of TB were reported in the US, with a rate of 2.5 cases per 100,000 people. As the tuberculin skin test is the main test for the disease diagnosis, the demand for intradermal injections is high, which is increasing the market size of this segment.

Furthermore, the increasing adoption of technological advancements and rising R&D activities are projected to accelerate the growth of the intradermal injections market.

Intradermal Injection Market Regional Insights

The regional trends and factors influencing the Intradermal Injection Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Intradermal Injection Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Intradermal Injection Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Intradermal Injection Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Intradermal Injection Market are:

1. BD
2. Terumo Corporation
3. NanoPass
4. Pharmajet
5. Idevax
6. Eunsung Global

Disclaimer: The companies listed above are not ranked in any particular order.

Intradermal Injection Market News and Recent Developments

The Intradermal Injection market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes essential corporate publications, association data, and databases. A few of the developments in the Intradermal Injection market are listed below:

• NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass’s MicronJet 600 intradermal delivery device in the US. (Source: NanoPass Technologies, Press Release, November 2021).
• PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System. (Source: PharmaJet, Press Release, August 2021).

Intradermal Injection Market Report Coverage and Deliverables

The “Intradermal Injection Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Intradermal injection market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Intradermal injection market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Intradermal injection market analysis covering key market trends, global and regional framework, significant players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the intradermal injection market
• Detailed company profiles